PTO- 1478 |
Approved for use through 04/30/2021. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 90680757 |
Filing Date: 04/29/2021 |
Input Field |
Entered |
SERIAL NUMBER | 90680757 |
---|---|
MARK INFORMATION | |
*MARK | \\TICRS\EXPORT18\IMAGEOUT 18\906\807\90680757\xml1 \ APP0002.JPG |
SPECIAL FORM | YES |
USPTO-GENERATED IMAGE | NO |
LITERAL ELEMENT | AGT |
COLOR MARK | NO |
*DESCRIPTION OF THE MARK (and Color Location, if applicable) |
The mark consists of of the wording AGT in all capital letters within a ring formed by a double helix centered within a square. |
PIXEL COUNT ACCEPTABLE | YES |
PIXEL COUNT | 368 x 367 |
REGISTER | Principal |
APPLICANT INFORMATION | |
*OWNER OF MARK | American Gene Technologies International Inc. |
*MAILING ADDRESS | 9640 Medical Center Drive |
*CITY | Rockville |
*STATE (Required for U.S. applicants) |
Maryland |
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
*ZIP/POSTAL CODE (Required for U.S. and certain international addresses) |
20850 |
*EMAIL ADDRESS | XXXX |
LEGAL ENTITY INFORMATION | |
TYPE | corporation |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION | Delaware |
GOODS AND/OR SERVICES AND BASIS INFORMATION | |
INTERNATIONAL CLASS | 005 |
*IDENTIFICATION | Pharmaceuticals, medicinal and biological preparations for modulation of patient gene expression for the treatment of diseases and conditions associated with cancer, immunological based disorders, auto-immunological based disorders, and infectious disease as may be caused by viruses, bacteria, and fungi, and inherited diseases, namely, metabolic, skeletal, muscular, dermal and neurodegenerative disorders, and for the treatment of injury, trauma, burns, or bone fractures, namely, repair of vasculature and re-innervation of tissues, and cosmetic or reconstructive tissue modification |
FILING BASIS | SECTION 1(b) |
INTERNATIONAL CLASS | 041 |
*IDENTIFICATION | Providing online newsletters in the fields of pharmaceuticals, medicines, treatments of diseases and medical disorders, and health; providing online non-downloadable videos in the fields of pharmaceuticals, medicines, treatments of diseases and medical disorders; online journals, namely, blogs featuring pharmaceuticals, medicines, treatments of diseases and medical disorders; educational services, namely, conducting programs in the fields of pharmaceuticals, medicines, treatments of diseases and medical disorders |
FILING BASIS | SECTION 1(b) |
INTERNATIONAL CLASS | 044 |
*IDENTIFICATION | Medical testing services relating to the diagnosis and treatment of disease; medical diagnostic testing, monitoring and reporting services; genetic testing for medical purposes |
FILING BASIS | SECTION 1(b) |
ATTORNEY INFORMATION | |
NAME | Richard Y. Kim |
ATTORNEY DOCKET NUMBER | 70612.04300 |
ATTORNEY BAR MEMBERSHIP NUMBER | XXX |
YEAR OF ADMISSION | XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY | XX |
FIRM NAME | Snell & Wilmer L.L.P. |
INTERNAL ADDRESS | One Arizona Center |
STREET | 400 East Van Buren Street, Suite 1900 |
CITY | Phoenix |
STATE | Arizona |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
ZIP/POSTAL CODE | 85004-2202 |
PHONE | 202-908-4263 |
FAX | 602.382.6070 |
EMAIL ADDRESS | TMDocket@swlaw.com |
OTHER APPOINTED ATTORNEY | all others |
CORRESPONDENCE INFORMATION | |
NAME | Richard Y. Kim |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | TMDocket@swlaw.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | rkim@swlaw.com; ksandacz@swlaw.com |
FEE INFORMATION | |
APPLICATION FILING OPTION | TEAS Standard |
NUMBER OF CLASSES | 3 |
APPLICATION FOR REGISTRATION PER CLASS | 350 |
*TOTAL FEES DUE | 1050 |
*TOTAL FEES PAID | 1050 |
SIGNATURE INFORMATION | |
SIGNATURE | /Richard Y. Kim/ |
SIGNATORY'S NAME | Richard Y. Kim |
SIGNATORY'S POSITION | Attorney of Record, DC Bar Member |
SIGNATORY'S PHONE NUMBER | 202-908-4263 |
DATE SIGNED | 04/29/2021 |
SIGNATURE METHOD | Signed directly within the form |
PTO- 1478 |
Approved for use through 04/30/2021. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 90680757 |
Filing Date: 04/29/2021 |
The applicant's current Correspondence Information: |
Richard Y. Kim |
PRIMARY EMAIL FOR CORRESPONDENCE: TMDocket@swlaw.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): rkim@swlaw.com; ksandacz@swlaw.com Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS). |
|
|